<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39314786</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Bacterial infections and outcomes of inpatients with COVID-19 in the intensive care unit during the delta-dominant phase: the worst wave of pandemic in Iran.</ArticleTitle><Pagination><StartPage>1411314</StartPage><MedlinePgn>1411314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1411314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1411314</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Epidemiological data regarding the prevalence of bacterial multidrug-resistant (MDR) Gram-negative infections in patients with COVID-19 in Iran are still ambiguous. Thus, in this study we have investigated the epidemiology, risk factors for death, and clinical outcomes of bacterial infections among patients with COVID-19 in the intensive care unit (ICU).</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">This retrospective cohort study included patients with COVID-19 hospitalized in the ICU of a university hospital in Iran between June 2021 and December 2021. We evaluated the epidemiological, clinical, and microbiological features, outcomes and risk factors associated with death among all COVID-19 patients. Data and outcomes of these patients with or without bacterial infections were compared. Kaplan-Meier plot was used for survival analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In total, 505 COVID-19 patients were included. The mean age of the patients was 52.7 ± 17.6 years and 289 (57.2%) were female. The prevalence of bacterial infections among hospitalized patients was 14.9%, most of them being hospital-acquired superinfections (13.3%). MDR <i>Klebsiella pneumoniae</i> and <i>Staphylococcus aureus</i> were the most common pathogens causing respiratory infections. Urinary tract infections were most frequently caused by MDR <i>Escherichia coli</i> and <i>K. pneumoniae</i>. The overall in-hospital mortality rate of COVID-19 patients was 46.9% (237/505), while 78.7% (59/75) of patients with bacterial infections died. Infection was significantly associated with death (OR 6.01, 95% CI = 3.03-11.92, <i>p</i>-value &lt;0.0001) and a longer hospital stay (<i>p</i> &lt; 0.0001). Multivariate logistic regression analysis showed that Age (OR = 1.04, 95% CI = 1.03-1.06, <i>p</i>-value &lt;0.0001), Sex male (OR = 1.70, 95% CI = 1.08-2.70, <i>p</i>-value &lt;0.0001), Spo2 (OR = 1.99, 95% CI = 1.18-3.38, <i>p</i>-value = 0.010) and Ferritin (OR = 2.33, 95% CI = 1.37-3.97, <i>p</i>-value = 0.002) were independent risk factors associated with in-hospital mortality. Furthermore, 95.3% (221/232) of patients who were intubated died.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our findings demonstrate that bacterial infection due to MDR Gram-negative bacteria associated with COVID-19 has an expressive impact on increasing the case mortality rate, reinforcing the importance of the need for surveillance and strict infection control rules to limit the expansion of almost untreatable microorganisms.</AbstractText><CopyrightInformation>Copyright © 2024 Akbari, Dehghani, Shirzadi, Pourajam, Hosseinzadeh, Sajadi, Alenaseri, Siavash, Jafari and Solgi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Mojtaba</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehghani</LastName><ForeName>Yeganeh</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirzadi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourajam</LastName><ForeName>Samaneh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseinzadeh</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Biology, School of Medicine Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sajadi</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenaseri</LastName><ForeName>Malihe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siavash</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafari</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solgi</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024901" MajorTopicYN="N">Drug Resistance, Multiple, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Iran</Keyword><Keyword MajorTopicYN="N">bacterial infection</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">multi-drug resistant</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39314786</ArticleId><ArticleId IdType="pmc">PMC11416957</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1411314</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Russell CD, Fairfield CJ, Drake TM, Turtle L, Seaton RA, Wootton DG, et al. . Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. (2021) 2:e354–65. doi: 10.1016/S2666-5247(21)00090-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00090-2</ArticleId><ArticleId IdType="pmc">PMC8172149</ArticleId><ArticleId IdType="pubmed">34100002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054–62. doi: 10.1016/S0140-6736(20)30566-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghdadi JD, Coffey KC, Adediran T, Goodman KE, Pineles L, Magder LS, et al. . Antibiotic use and bacterial infection among inpatients in the first wave of COVID-19: a retrospective cohort study of 64, 691 patients. Antimicrob Agents Chemother. (2021) 65:e0134121. doi: 10.1128/AAC.01341-21, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01341-21</ArticleId><ArticleId IdType="pmc">PMC8522758</ArticleId><ArticleId IdType="pubmed">34491806</ArticleId></ArticleIdList></Reference><Reference><Citation>De Francesco MA, Signorini L, Piva S, Pellizzeri S, Fumarola B, Corbellini S, et al. . Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome. J Med Virol. (2023) 95:e28892. doi: 10.1002/jmv.28892</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28892</ArticleId><ArticleId IdType="pubmed">37394790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajic I, Jovicevic M, Popadic V, Trudic A, Kabic J, Kekic D, et al. . The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-Centre study. J Hosp Infect. (2023) 137:1–7. doi: 10.1016/j.jhin.2023.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.04.013</ArticleId><ArticleId IdType="pmc">PMC10140260</ArticleId><ArticleId IdType="pubmed">37121488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardi T, Pintado V, Gomez-Rojo M, Escudero-Sanchez R, Azzam Lopez A, Diez-Remesal Y, et al. . Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. (2021) 40:495–502. doi: 10.1007/s10096-020-04142-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04142-w</ArticleId><ArticleId IdType="pmc">PMC7778834</ArticleId><ArticleId IdType="pubmed">33389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourajam S, Kalantari E, Talebzadeh H, Mellali H, Sami R, Soltaninejad F, et al. . Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic Hospital in Iran during the first wave of the pandemic. Front Cell Infect Microbiol. (2022) 12:784130. doi: 10.3389/fcimb.2022.784130</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.784130</ArticleId><ArticleId IdType="pmc">PMC8904895</ArticleId><ArticleId IdType="pubmed">35281440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. . Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. (2021) 27:451–7. doi: 10.1016/j.cmi.2020.10.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.10.021</ArticleId><ArticleId IdType="pmc">PMC7584496</ArticleId><ArticleId IdType="pubmed">33223114</ArticleId></ArticleIdList></Reference><Reference><Citation>Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. (2008) 36:309–32. doi: 10.1016/j.ajic.2008.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2008.03.002</ArticleId><ArticleId IdType="pubmed">18538699</ArticleId></ArticleIdList></Reference><Reference><Citation>Timpau AS, Miftode RS, Costache II, Petris AO, Miftode IL, Gheorghe L, et al. . An overview of the impact of bacterial infections and the associated mortality predictors in patients with COVID-19 admitted to a tertiary center from Eastern Europe. Antibiotics (Basel). (2023) 12:1–18. doi: 10.3390/antibiotics12010144</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12010144</ArticleId><ArticleId IdType="pmc">PMC9854454</ArticleId><ArticleId IdType="pubmed">36671345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SM, Lee J, Lee SM, Lee HY. Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19. Front Med (Lausanne). (2023) 10:1079721. doi: 10.3389/fmed.2023.1079721</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1079721</ArticleId><ArticleId IdType="pmc">PMC10017481</ArticleId><ArticleId IdType="pubmed">36936237</ArticleId></ArticleIdList></Reference><Reference><Citation>Baiou A, Elbuzidi AA, Bakdach D, Zaqout A, Alarbi KM, Bintaher AA, et al. . Clinical characteristics and risk factors for the isolation of multi-drug-resistant gram-negative bacteria from critically ill patients with COVID-19. J Hosp Infect. (2021) 110:165–71. doi: 10.1016/j.jhin.2021.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.01.027</ArticleId><ArticleId IdType="pmc">PMC7866848</ArticleId><ArticleId IdType="pubmed">33561503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerver SM, Guy R, Wilson K, Thelwall S, Nsonwu O, Rooney G, et al. . National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave. Clin Microbiol Infect. (2021) 27:1658–65. doi: 10.1016/j.cmi.2021.05.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.040</ArticleId><ArticleId IdType="pmc">PMC8186130</ArticleId><ArticleId IdType="pubmed">34481722</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourajam S, Zafarbakhsh A, Hosseinzadeh M, Shirzadi M, Siavash M, Solgi H. Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19. J Pharmaceutical Policy Prac. (2023) 16:38. doi: 10.1186/s40545-023-00547-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40545-023-00547-y</ArticleId><ArticleId IdType="pmc">PMC9983522</ArticleId><ArticleId IdType="pubmed">36869363</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell R, Urgelés S, Rodríguez A, Bodí M, Martín-Loeches I, Solé-Violán J, et al. . Mortality comparison between the first and second/third waves among 3, 795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study. Lancet Reg Health Eur. (2021) 11:100243. doi: 10.1016/j.lanepe.2021.100243</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100243</ArticleId><ArticleId IdType="pmc">PMC8566166</ArticleId><ArticleId IdType="pubmed">34751263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudiol C, Durà-Miralles X, Aguilar-Company J, Hernández-Jiménez P, Martínez-Cutillas M, Fernandez-Avilés F, et al. . Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study. J Inf Secur. (2021) 83:306–13. doi: 10.1016/j.jinf.2021.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.07.014</ArticleId><ArticleId IdType="pmc">PMC8295054</ArticleId><ArticleId IdType="pubmed">34302864</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. . Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. (2021) 27:83–8. doi: 10.1016/j.cmi.2020.07.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.041</ArticleId><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, et al. . Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. (2021) 73:e445–54. doi: 10.1093/cid/ciaa954</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa954</ArticleId><ArticleId IdType="pmc">PMC7454462</ArticleId><ArticleId IdType="pubmed">32651997</ArticleId></ArticleIdList></Reference><Reference><Citation>de Macedo V, Santos GS, Silva RN, Couto CNM, Bastos C, Viecelli E, et al. . Healthcare-associated infections: a threat to the survival of patients with COVID-19 in intensive care units. J Hosp Infect. (2022) 126:109–15. doi: 10.1016/j.jhin.2022.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2022.05.013</ArticleId><ArticleId IdType="pmc">PMC9131443</ArticleId><ArticleId IdType="pubmed">35623469</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MJ, Orihuela CJ, Harrod KS, Bhuiyan MAN, Dominic P, Kevil CG, et al. . COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit Care. (2023) 27:34. doi: 10.1186/s13054-023-04312-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04312-0</ArticleId><ArticleId IdType="pmc">PMC9868503</ArticleId><ArticleId IdType="pubmed">36691080</ArticleId></ArticleIdList></Reference><Reference><Citation>Huyut MT, Huyut Z. Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: a strong prediction with the decision trees. Heliyon. (2023) 9:e14015. doi: 10.1016/j.heliyon.2023.e14015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e14015</ArticleId><ArticleId IdType="pmc">PMC9985543</ArticleId><ArticleId IdType="pubmed">36919085</ArticleId></ArticleIdList></Reference><Reference><Citation>Bepouka B, Situakibanza H, Sangare M, Mandina M, Mayasi N, Longokolo M, et al. . Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis. J Clin Hypertens (Greenwich). (2022) 24:99–105. doi: 10.1111/jch.14417</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.14417</ArticleId><ArticleId IdType="pmc">PMC8845466</ArticleId><ArticleId IdType="pubmed">35083847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikram AS, Pillay S. Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study. BMC Emerg Med. (2022) 22:68. doi: 10.1186/s12873-022-00631-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12873-022-00631-7</ArticleId><ArticleId IdType="pmc">PMC9051839</ArticleId><ArticleId IdType="pubmed">35488200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejía F, Medina C, Cornejo E, Morello E, Vásquez S, Alave J, et al. . Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. (2020) 15:e0244171. doi: 10.1371/journal.pone.0244171</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244171</ArticleId><ArticleId IdType="pmc">PMC7769479</ArticleId><ArticleId IdType="pubmed">33370364</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A, Rachoin JS, Schorr C, Dellinger P, Casey JD, Park I, et al. . Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: a multicenter cohort study. PLoS One. (2023) 18:e0285748. doi: 10.1371/journal.pone.0285748</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0285748</ArticleId><ArticleId IdType="pmc">PMC10306211</ArticleId><ArticleId IdType="pubmed">37379286</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti S, Carsin AE, Sampol J, Pallero M, Aldas I, Marin T, et al. . Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP. Sci Rep. (2022) 12:6527. doi: 10.1038/s41598-022-10475-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10475-7</ArticleId><ArticleId IdType="pmc">PMC9020755</ArticleId><ArticleId IdType="pubmed">35444251</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana MV, Pellegrini JAS, Perez AV, Schwarz P, da Silva D, Teixeira C, et al. . Association between prolonged corticosteroids use in COVID-19 and increased mortality in hospitalized patients: a retrospective study with inverse probability of treatment weighting analysis. Crit Care. (2023) 27:143. doi: 10.1186/s13054-023-04434-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04434-5</ArticleId><ArticleId IdType="pmc">PMC10105528</ArticleId><ArticleId IdType="pubmed">37061719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>